Vanguard Group’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $263M | Buy |
|
|||||
|
2025
Q1 | $273M | Sell |
|
|||||
|
2024
Q4 | $274M | Buy |
|
|||||
|
2024
Q3 | $424M | Buy |
|
|||||
|
2024
Q2 | $243M | Buy |
|
|||||
|
2024
Q1 | $98.1M | Sell |
|
|||||
|
2023
Q4 | $36.6M | Buy |
|
|||||
|
2023
Q3 | $25.6M | Buy |
|
|||||
|
2023
Q2 | $44M | Buy |
|
|||||
|
2023
Q1 | $53.4M | Buy |
|
|||||
|
2022
Q4 | $77M | Buy |
|
|||||
|
2022
Q3 | $44.1M | Buy |
|
|||||
|
2022
Q2 | $35.2M | Buy |
|
|||||
|
2022
Q1 | $42.5M | Buy |
|
|||||
|
2021
Q4 | $47.6M | Buy |
|
|||||
|
2021
Q3 | $47.8M | Buy |
|
|||||
|
2021
Q2 | $31.4M | Sell |
|
|||||
|
2021
Q1 | $28M | Buy |
|
|||||
|
2020
Q4 | $20.8M | Buy |
|
|||||
|
2020
Q3 | $21.1M | Buy |
|
|||||
|
2020
Q2 | $565K | Buy |
|